Opus Genetics, Inc. (IRD)
4.23
+0.03
(+0.71%)
USD |
NASDAQ |
Nov 10, 16:00
4.24
+0.01
(+0.24%)
After-Hours: 20:00
Opus Genetics Total Assets (Quarterly) : 95.30M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.30M |
| June 30, 2026 | 92.97M |
| March 31, 2026 | 66.79M |
| December 31, 2025 | 50.27M |
| September 30, 2025 | 36.12M |
| June 30, 2025 | 38.66M |
| March 31, 2025 | 48.17M |
| December 31, 2024 | 36.89M |
| September 30, 2024 | 40.39M |
| June 30, 2024 | 44.83M |
| March 31, 2024 | 51.84M |
| December 31, 2023 | 53.95M |
| September 30, 2023 | 54.19M |
| June 30, 2023 | 43.46M |
| March 31, 2023 | 45.40M |
| December 31, 2022 | 48.99M |
| September 30, 2022 | 14.57M |
| June 30, 2022 | 17.90M |
| March 31, 2022 | 20.48M |
| December 31, 2021 | 26.08M |
| September 30, 2021 | 23.20M |
| June 30, 2021 | 25.25M |
| March 31, 2021 | 12.13M |
| December 31, 2020 | |
| September 30, 2020 | 8.834M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.25M |
| March 31, 2020 | 11.55M |
| December 31, 2019 | 12.97M |
| September 30, 2019 | 14.98M |
| June 30, 2019 | 17.68M |
| March 31, 2019 | 19.43M |
| December 31, 2018 | 16.04M |
| September 30, 2018 | 13.87M |
| June 30, 2018 | 18.24M |
| March 31, 2018 | 22.55M |
| December 31, 2017 | 28.29M |
| September 30, 2017 | 24.59M |
| June 30, 2017 | 28.09M |
| March 31, 2017 | 19.61M |
| December 31, 2016 | 21.04M |
| September 30, 2016 | 22.74M |
| June 30, 2016 | 20.53M |
| March 31, 2016 | 25.56M |
| December 31, 2015 | 24.80M |
| September 30, 2015 | 23.07M |
| June 30, 2015 | 27.37M |
| March 31, 2015 | 30.48M |
| December 31, 2014 | 33.53M |
| September 30, 2014 | 36.45M |
| June 30, 2014 | 39.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Rezolute, Inc. | 96.01M |
| Faeth Therapeutics, Inc. | 178.95M |
| Nuvectis Pharma, Inc. | 140.84M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 56.86M |
| Shareholders Equity (Quarterly) | 38.43M |
| Debt to Equity Ratio | 0.8985 |
| Current Ratio | 9.648 |
| Net Debt Paydown Yield | -1.45% |